Smith & Nephew (SN) Shares Up 0%
Smith & Nephew plc (LON:SN)’s share price shot up 0% on Friday . The company traded as high as GBX 1,287 ($17.21) and last traded at GBX 1,285.50 ($17.19). 2,508,938 shares were traded during trading, an increase of 18% from the average session volume of 2,130,000 shares. The stock had previously closed at GBX 1,285.50 ($17.19).
SN has been the topic of several research reports. Berenberg Bank reissued a “hold” rating and set a GBX 1,340 ($17.92) target price on shares of Smith & Nephew in a research note on Friday, November 3rd. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 1,382 ($18.48) target price on shares of Smith & Nephew in a research note on Monday, November 6th. Deutsche Bank increased their target price on Smith & Nephew from GBX 1,200 ($16.04) to GBX 1,315 ($17.58) and gave the stock a “hold” rating in a research note on Monday, October 23rd. Jefferies Group reissued a “buy” rating and set a GBX 1,515 ($20.26) target price on shares of Smith & Nephew in a research note on Thursday, October 12th. Finally, Citigroup reissued a “sell” rating and set a GBX 1,160 ($15.51) target price on shares of Smith & Nephew in a research note on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of GBX 1,315.82 ($17.59).
The stock has a market capitalization of $11,000.00 and a PE ratio of 1,785.42.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.